Cargando…
Understanding the SARS-CoV-2 Virus Neutralizing Antibody Response: Lessons to Be Learned from HIV and Respiratory Syncytial Virus
The SARS-CoV-2 pandemic commenced in 2019 and is still ongoing. Neither infection nor vaccination give long-lasting immunity and, here, in an attempt to understand why this might be, we have compared the neutralizing antibody responses to SARS-CoV-2 with those specific for human immunodeficiency vir...
Autores principales: | Dimmock, Nigel J., Easton, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961721/ https://www.ncbi.nlm.nih.gov/pubmed/36851717 http://dx.doi.org/10.3390/v15020504 |
Ejemplares similares
-
Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
por: Wen, Xiaolin, et al.
Publicado: (2017) -
Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases
por: Dimmock, Nigel J., et al.
Publicado: (2015) -
The Susceptibilities of Respiratory Syncytial Virus to Nucleolin Receptor Blocking and Antibody Neutralization Are Dependent upon the Method of Virus Purification
por: Bilawchuk, Leanne M., et al.
Publicado: (2017) -
Kinetics of the Neutralizing Antibody Response to Respiratory Syncytial Virus Infections in a Birth Cohort
por: Sande, CJ, et al.
Publicado: (2013) -
Influenza, respiratory syncytial virus and SARS
por: Thompson, Catherine, et al.
Publicado: (2009)